Dr K M Ho, Intensive Care Unit, Royal Perth Hospital, Perth, WA 6000, Australia; kwok.ho{at}health.wa.gov.au Objectives: To assess the effects of intravenous magnesium on converting acute onset atrial ...
Correspondence to Dr Carolyn Y Ho, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA; cho{at}bwh.harvard.edu Genetic testing in hypertrophic cardiomyopathy (HCM) is a ...
Introduction Transcatheter Aortic Valve Implantation (TAVI) is an established treatment option for severe aortic stenosis (AS), with over 5000 procedures performed in the UK in 2019. Given the high ...
1 The Affiliated Luohu Hospital, Shenzhen University Health Science Center, Shenzhen, China Objective Studies investigating the impact of chocolate consumption on cardiovascular disease (CVD) have ...
Correspondence to Dr Ian Ford, University of Glasgow Robertson Centre for Biostatistics, Glasgow G12 8QQ, UK; ian.ford{at}glasgow.ac.uk Methods IRONMAN is a prospective, randomised, open-label, ...
Dr S H Schirmer, Department of Cardiology, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Stephan.schirmer{at}uks.eu Collateral artery growth is a potent natural defence ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Atrial fibrillation (AF) is the commonest atrial arrhythmia and represents a large burden on modern health services. Large multicentre randomised trials have demonstrated that a rhythm control ...
Department of Pharmacology, CV Therapeutics, Inc, Palo Alto, California, USA Correspondence to: Dr Luiz Belardinelli Department of Pharmacological Sciences, CV ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...